Cindy Berrie Group
Research in our group has focused on the effect of nanoscale structure on 1) biomolecule adsorption, 2) friction and adhesion, and 3) electrical conductivity of organic molecules. In all of these cases, we are interested in designing model systems in which the nanoscale structural and chemical variations can be achieved.
Heather Desaire Group
Our research focuses on developing mass spectrometric methods for analyzing glycoproteins and small organic molecules (like pharmaceuticals and metabolites). This research has many different potential applications to human health, from identifying markers for diseases to identifying the potent form of hormone therapies.
Bob Dunn Group
Our group utilizes several high resolution microscopy techniques to study biological processes at the single molecule level. Currently, we have ongoing projects studying the conformational dynamics of protein channels and the submicron structure and dynamics of thin lipid films.
Mei He Group
Major efforts in our research group are dedicated to the innovative bioengineering solutions to human health, via device-level fabrication, material- level characterization, and biomolecular-level quantitation. We have developed a combination of 3D cell culture and bioprinting, 3D microfabrication of nano-biomaterials, biomedical microfluidic devices and sensing approaches, for designing, programming and monitoring biomimetic immunity, associated with extracellular vesicles-based communications.
Carey Johnson Group
Single-molecule, single-photon methods are currently being used to examine dynamics and conformations of calmodulin and calmodulin target recognition and activation. Our study of orientational dynamics is aimed at understanding the motions of solute molecules in their solvent environment.
Michael Johnson Group
The goal of our research program is the development and application of bioanalytical techniques capable of studying the process of neuron communication via the release of neurotransmitters at the pre-synaptic terminal, a process called exocytosis.
Jeff Krise Group
The research in our laboratory is focused on understanding driving forces important in the transport and/or distribution of small molecule type drugs within the array of intracellular compartments contained within mammalian cells.
Sue Lunte Group
Our research group is focused on the development of sensitive and selective analytical methods for the detection of peptides, amino acids, neurotransmitters, and drugs in biological fluids.
Karen Nordheden Group
The Plasma Research Laboratory is currently collaborating with engineers in industry and government laboratories who have provided us with materials and additional testing capabilities. Our current research deals with the development of etch processes for wide bandgap semiconductors such as SiC, GaN, and ZnO.
Christian Schöneich Group
Professor Schöneich's research focuses on the oxidative post-translational modification of proteins in vitro and in vivo.
Steve Soper Group
The major focus of our group is to generate new tools for discovery and medical diagnostics through the analysis of biological macromolecules including DNAs, RNAs and proteins. These tools cover a diverse range of activities, such as the generation of new reagents, novel assays and methodologies, and hardware innovations across various length scales (millimeter to nanometer).
John Stobaugh Group
Professor Stobaugh's research emphasizes liquid phase capillary column separation techniques (capillary electrochromatography, capillary liquid chromatography and capillary electrophoresis) and various chemistries for the enhancement of separation and detection.
David Weis Group
We are interested in the mechanisms by which intrinsically disordered proteins mediate interactions with their binding partners. Our lab uses amide H/D exchange coupled with HPLC and time of flight mass spectrometry to probe these interactions.
Yong Zeng Group
We are currently focused on three main areas: (1) Quantitative single cell analysis for cancer biology and clinical medicine; (2) high-throughput glycoproteomics and glycomics; and (3) nanomaterial enabled bioanalytical technologies.